Results 91 to 100 of about 239,525 (205)

Serogroup B meningococcal vaccine booster doses [PDF]

Meningococcal-2-Mbaeyi-508 ...

core  

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease

Expert Review of Vaccines
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde, Chiranjiwi Bhusal, Catherine A. Cosgrove, Woo-Yun Sohn   +3 more
doaj   +1 more source

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

Journal of Immunology Research, 2015
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini, D. Panatto, N. L. Bragazzi, P. L. Lai, A. Bechini, M. Levi, P. Durando, D. Amicizia   +7 more
doaj   +1 more source

Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel), 2023
Conti A, Broglia G, Sacchi C, Risi F, Barone-Adesi F, Panella M.   +5 more
europepmc   +1 more source

Updated ACIP statement for meningococcal vaccination in the United States [PDF]

Meningococcal-3-Mbaeyi-508 ...

core  

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. [PDF]

Am J Epidemiol, 2022
Prunas O, Weinberger DM, Medini D, Tizzoni M, Argante L.   +4 more
europepmc   +1 more source

Carbohydrate based meningococcal vaccines: past and present overview. [PDF]

Glycoconj J, 2021
Berti F, Romano MR, Micoli F, Adamo R.
europepmc   +1 more source

Plan for revisiting the adolescent schedule for meningococcal vaccines [PDF]

02-Meningococcal-McNamara-508 ...

core  

The challenge of post-implementation surveillance for novel meningococcal vaccines.

, 2016
Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in mass immunisation campaigns over the coming years. This represents an exciting development in the prevention of childhood meningitis, however monitoring ...

core   +1 more source

Is meningococcal B vaccination needed in the post-COVID-19 world?

Biomédica: revista del Instituto Nacional de Salud
Neisseria meningitidis is the main cause of bacterial meningitis worldwide and is transmitted through respiratory secretions. Meningitis is a serious public health problema because of its high morbidity and mortality rates and the risk of causing ...
Amanda Izeli Portilho, Elizabeth De Gaspari   +1 more
doaj   +1 more source